Expression of erythrocyte binding protein in Plasmodium falciparum merozoites isolated from endemic area
流行区恶性疟原虫裂殖子中红细胞结合蛋白的表达
基本信息
- 批准号:13576007
- 负责人:
- 金额:$ 8.7万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2001
- 资助国家:日本
- 起止时间:2001 至 2002
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Mutant erythrocyte that lacked certain proteins on the surface were frequently observed in the malaria endemic areas, and some of them were believed to be generated by the selective advantage against malaria infection. However, Plasmodium falciparum have an ability to invade many types of erythrocyte including these mutant erythrocytes. The molecular base of this ability of P.falciparum could be resulted by the erythrocyte-binding proteins encoded in the multi-gene family involved in the invasion steps. In this study, we explored the possibility if P.falciparum regulated the expression of these multi-gene family in order to overcome the erythrocyte polymorphism by quantitate the transcription and protein expression level of each members of the multi-gene family, PfRhopH1.Firstly, we designed a panel of oligonucleotide primers for real-time PCR method with SYBR green. Complementary DNA was made from the 3D7 clone of P.falciparum and used to make plasmids containing the real-time PCR targets for each member. These plasmids were used to create the standard curve. P.falciparum field samples were collected in the malaria endemic area in Thailand and total RNA were extracted. Simultaneously blood smear were made on the glass slides for the IFA analysis for the protein expression. In order to check the protein expression level, we successfully generated anti-PfRhopHl_2, 3.1, 9 specific sera. Difference in the protein expression was observed among the culture-adapted P. falciparum clones.
在疟疾流行区经常观察到表面缺乏某些蛋白质的突变红细胞,其中一些被认为是由于对疟疾感染的选择性优势而产生的。然而,恶性疟原虫具有侵入包括这些突变红细胞在内的多种类型的红细胞的能力。恶性疟原虫这种能力的分子基础可能是由参与侵袭步骤的多基因家族中编码的红细胞结合蛋白所导致的。本研究通过对多基因家族PfRhopH1各成员的转录水平和蛋白表达水平的定量分析,探讨恶性疟原虫是否通过调控这些多基因家族的表达来克服红细胞的多态性。从恶性疟原虫的3D7克隆制备互补DNA,并用于制备含有每个成员的实时PCR靶标的质粒。这些质粒用于创建标准曲线。在泰国疟疾流行区采集恶性疟原虫现场样本,提取总RNA。同时在玻片上制作血涂片,用于IFA分析蛋白表达。为了检测蛋白表达水平,我们成功地制备了抗PfRhopHl_2、3.1、9特异性血清。在恶性疟原虫的培养适应克隆中观察到蛋白表达的差异。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ling IT, Kaneko O, Narum DL, Tsuboi T, et al.: "Characterization of the rhoph2 gene of Plasmodium falciparum and Plasmodium yoelii"Molecular and Biochemical Parasitology. 127 (1). 47-57 (2003)
Ling IT、Kaneko O、Narum DL、Tsuboi T 等人:“恶性疟原虫和约氏疟原虫的 rhoph2 基因的特征”分子和生化寄生虫学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kaneko O, Mu J, Tsuboi T, Su X, Torii M: "Gene structure and expression of a Plasmodium falciparum 220-kilodalton protein homologous to the Plasmodium vivax reticulocyte binding proteins"Molecular and Biochemical Parasitology. (in press).
Kaneko O、Mu J、Tsuboi T、Su X、Torii M:“与间日疟原虫网织红细胞结合蛋白同源的恶性疟原虫 220 千道尔顿蛋白的基因结构和表达”分子和生化寄生虫学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kaneko O, Mu J, Tsuboi T, Su X, Torii M.: "Gene structure and expression of a Plasmodium falciparum 220-kDa protein Homologous to the Plasmodium vivax reticulocyte binding proteins"Molecular and Biochemical Parasitology. 121(2). 275-278 (2002)
Kaneko O、Mu J、Tsuboi T、Su X、Torii M.:“与间日疟原虫网织红细胞结合蛋白同源的恶性疟原虫 220-kDa 蛋白的基因结构和表达”分子和生化寄生虫学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Ling IT, Kaneko O, Narum DL, Tsuboi T, Howwll S, Taylor HM, Scott-Finningan TJ, Torii M, Holder AA: "Characterization of the rhoph2 gene of Plasmodium falciparum and Plasmodium yoelii"Molecular and Biochemical Parasitology. 127(1). 47-57 (2003)
Ling IT、Kaneko O、Narum DL、Tsuboi T、Howwll S、Taylor HM、Scott-Finningan TJ、Torii M、Holder AA:“恶性疟原虫和约氏疟原虫的 rhoph2 基因的表征”分子和生化寄生虫学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Ling IT, Kaneko O, Narum DL, Tsuboi T, et al.: "Characterization of the rhoph2 gene of Plasmodium falciparum and Plasmodium yoelii"Molecular and Biochemical Parasitology. 127(1). 47-57 (2003)
Ling IT、Kaneko O、Narum DL、Tsuboi T 等人:“恶性疟原虫和约氏疟原虫的 rhoph2 基因的特征”分子和生化寄生虫学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TORII Motomi其他文献
TORII Motomi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TORII Motomi', 18)}}的其他基金
Development of novel transmission blocking vaccine targeting microgamete surface antigen of Plasmodium falciparum
针对恶性疟原虫小配子表面抗原的新型传播阻断疫苗的开发
- 批准号:
20H03480 - 财政年份:2020
- 资助金额:
$ 8.7万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Assessment of P. vivax transmission-blocking activity of novel vaccine candidate (PvGs24)
新型候选疫苗 (PvGs24) 间日疟原虫传播阻断活性的评估
- 批准号:
16H05816 - 财政年份:2016
- 资助金额:
$ 8.7万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of novel P. falciparum malaria transmission-blocking vaccine targeted against Pf75
开发针对 Pf75 的新型恶性疟原虫疟疾传播阻断疫苗
- 批准号:
15H04725 - 财政年份:2015
- 资助金额:
$ 8.7万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of novel malaria transmission blocking vaccine
新型疟疾传播阻断疫苗的开发
- 批准号:
21406010 - 财政年份:2009
- 资助金额:
$ 8.7万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Screening of sporozoite receptor molecule(s) on hepatocytes
肝细胞上子孢子受体分子的筛选
- 批准号:
21390124 - 财政年份:2009
- 资助金额:
$ 8.7万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Identification of erythrocyte proteins interacting with RhopH complex of malaria parasites
鉴定与疟原虫 RhopH 复合物相互作用的红细胞蛋白
- 批准号:
19390120 - 财政年份:2007
- 资助金额:
$ 8.7万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Rosetting of infected erythrocyte and virulence of Vivax malaria
受感染红细胞的玫瑰花结和间日疟疾的毒力
- 批准号:
18406009 - 财政年份:2006
- 资助金额:
$ 8.7万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Identification of the binding domain of Plasmodium falciparum erythrocyte binding protein.
恶性疟原虫红细胞结合蛋白结合域的鉴定。
- 批准号:
16390126 - 财政年份:2004
- 资助金额:
$ 8.7万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Identification of the erythrocyte receptor for Plasmodium yoelii RhopH complex
约氏疟原虫 RhopH 复合物红细胞受体的鉴定
- 批准号:
16017272 - 财政年份:2004
- 资助金额:
$ 8.7万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
Analysis of the protein expression level of the erythrocyte binding proteins in Plasmodium falciparum field isolates.
恶性疟原虫野外分离株中红细胞结合蛋白的蛋白表达水平分析。
- 批准号:
15406015 - 财政年份:2003
- 资助金额:
$ 8.7万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似国自然基金
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
- 批准号:82372275
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
户外杀蚊真菌农药研制(GC Malaria)
- 批准号:82261128004
- 批准年份:2022
- 资助金额:150.00 万元
- 项目类别:国际(地区)合作与交流项目
GC Malaria:研发昆虫不育技术用于控制城市疟疾媒介斯氏按蚊
- 批准号:82261128006
- 批准年份:2022
- 资助金额:130.00 万元
- 项目类别:国际(地区)合作与交流项目
GC Malaria - 利用按蚊天然抗疟共生菌阻断疟疾传播
- 批准号:
- 批准年份:2022
- 资助金额:150 万元
- 项目类别:
GC Malaria:高效实时户外疟疾媒介蚊虫诱捕监测技术和装置的研发
- 批准号:82261128003
- 批准年份:2022
- 资助金额:150.00 万元
- 项目类别:国际(地区)合作与交流项目
GC Malaria-基于中药源的媒介生物传染病防控技术及产品开发
- 批准号:82261128005
- 批准年份:2022
- 资助金额:150.00 万元
- 项目类别:国际(地区)合作与交流项目
GC malaria:户外诱杀蚊虫的真菌杀虫剂及其释放装置的研发和应用研究
- 批准号:82261128002
- 批准年份:2022
- 资助金额:150.00 万元
- 项目类别:国际(地区)合作与交流项目
相似海外基金
Genomics and sero-epidemiology of Plasmodium falciparum malaria in a pre-elimination setting
消灭前环境中恶性疟原虫疟疾的基因组学和血清流行病学
- 批准号:
10666280 - 财政年份:2023
- 资助金额:
$ 8.7万 - 项目类别:
Exocytosis of Plasmodium egress and invasion organelles
疟原虫出口和入侵细胞器的胞吐作用
- 批准号:
10888455 - 财政年份:2023
- 资助金额:
$ 8.7万 - 项目类别:
Comprehensive characterization of the genetic factors and the host immune response associated to protection from clinical Plasmodium vivax malaria
与预防临床间日疟原虫疟疾相关的遗传因素和宿主免疫反应的综合特征
- 批准号:
10634775 - 财政年份:2023
- 资助金额:
$ 8.7万 - 项目类别:
Optimising a High Efficacy Plasmodium vivax Malaria Vaccine (OptiViVax)
优化高效间日疟原虫疟疾疫苗 (OptiViVax)
- 批准号:
10079676 - 财政年份:2023
- 资助金额:
$ 8.7万 - 项目类别:
EU-Funded
Extent, dynamics and mechanisms of Plasmodium vivax immune evasion caused by PvDBP gene amplification
PvDBP基因扩增引起间日疟原虫免疫逃避的程度、动态及机制
- 批准号:
10734028 - 财政年份:2023
- 资助金额:
$ 8.7万 - 项目类别:
Parasite and host cell factors involved in the formation and persistence of Plasmodium vivax hypnozoites
寄生虫和宿主细胞因子参与间日疟原虫休眠子的形成和持续存在
- 批准号:
10564073 - 财政年份:2023
- 资助金额:
$ 8.7万 - 项目类别:
Impairment of anti-Plasmodium T cell memory by type I Interferon Signaling
I 型干扰素信号传导损害抗疟原虫 T 细胞记忆
- 批准号:
10735305 - 财政年份:2023
- 资助金额:
$ 8.7万 - 项目类别:
Hijacking Plasmodium ubiquitin-proteasome system to defeat drug resistance
劫持疟原虫泛素蛋白酶体系统以击败耐药性
- 批准号:
10719157 - 财政年份:2023
- 资助金额:
$ 8.7万 - 项目类别:
Elucidating mechanisms for artemisinin-induced dormancy in Plasmodium falciparum
阐明青蒿素诱导恶性疟原虫休眠的机制
- 批准号:
10742385 - 财政年份:2023
- 资助金额:
$ 8.7万 - 项目类别:
Optimising a High Efficacy Plasmodium vivax Malaria Vaccine (OptiViVax)
优化高效间日疟原虫疟疾疫苗 (OptiViVax)
- 批准号:
10077974 - 财政年份:2023
- 资助金额:
$ 8.7万 - 项目类别:
EU-Funded














{{item.name}}会员




